Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
letter
. 2024 May 13;47(5):e24281. doi: 10.1002/clc.24281

Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end‐stage kidney disease patients undergoing hemodialysis

Szu‐Ying Lee 1, Chia‐Ter Chao 2,3,4,
PMCID: PMC11089592  PMID: 38738580

To the Editor,

Dong et al. investigated the relationship between interdialytic home blood pressure variability (BPV) and mortality in individuals with end‐stage kidney disease (ESKD) undergoing hemodialysis. 1 Their study revealed a notable correlation between increasing home BPV and a stepwise escalation in the risk of all‐cause mortality among this population. In the discussion, the authors attributed this association to comorbid cardiovascular diseases, diabetes, systemic inflammation, and higher vascular stiffness. We believe that a more comprehensive characterization of vascular integrity impairment is needed to explain this BPV‐outcome association.

Our team previously introduced the concept of vascular frailty, which elucidates vascular structural and functional degeneration leading to physical frailty or the coexistence of both phenotypes. 2 Vascular tissues are exquisitely susceptible to adverse consequences related to tissue senescence from chronological aging and metabotoxic stimuli, particularly uremic toxins. Vascular frailty manifests through structural degenerations such as vascular calcification and atherosclerosis, as well as functional perturbations like increased stiffness and vasomotor dysfunction. Uremic toxins predispose individuals with chronic kidney disease to developing physical frailty 3 and contribute to the pathogenesis of vascular frailty by inducing vascular calcification and increasing vascular stiffness, 4 thereby leading to higher BPV. It is widely acknowledged that ESKD patients are prone to developing vascular calcification over time. Moreover, individuals with ESKD exhibit accelerated aging and heightened tissue wear, culminating in physical frailty that significantly elevates mortality risk. Our previous findings demonstrated that ESKD patients with frailty faced a significantly higher risk of mortality compared with those without. 5

From this perspective, we recommend that the authors consider incorporating additional features of vascular frailty, such as measurements of vascular calcification severity and evidence of autonomic dysfunction, in their assessments of these patients. Doing so will facilitate a more thorough understanding of the mechanisms underlying the BPV‐outcome association.

AUTHOR CONTRIBUTIONS

Szu‐Ying Lee and Chia‐Ter Chao are responsible for drafting of this manuscript.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ACKNOWLEDGMENTS

The authors are grateful to the Second Core Laboratory, Department of Medical Research of National Taiwan University Hospital and the Genomic Research Center of National Taiwan University College of Medicine for their technical input. The study is financially sponsored by National Taiwan University Hospital Yunlin branch and National Science and Technology Council, Taiwan (NSTC 112‐2314‐B‐002‐232‐MY3).

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

REFERENCES

  • 1. Dong L, Tian M, Li H, Dong J, Song X. Interdialystic home systolic blood pressure variability increases all‐cause mortality in hemodialysis patients. Clin Cardiol. 2024;47:e24259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Chao CT, Hung KY. Vascular frailty, a proposal for new frailty type: a narrative review. Kaohsiung J Med Sci. 2023;39(4):318‐325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Chao CT, Lin SH. Uremic toxins and frailty in patients with chronic kidney disease: a molecular insight. Int J Mol Sci. 2021;22(12):6270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ding N, Lv Y, Su H, et al. Vascular calcification in CKD: new insights into its mechanisms. J Cell Physiol. 2023;238(6):1160‐1182. [DOI] [PubMed] [Google Scholar]
  • 5. Chao CT, Huang JW, Chiang CK, Hung KY Applicability of laboratory deficit‐based frailty index in predominantly older patients with end‐stage renal disease under chronic dialysis: a pilot test of its correlation with survival and self‐reported instruments. Nephrology 2020;25(1):73‐81. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.


Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES